Nagasaki University and NEC Corporation have established a program on global health & biometric authentication with ...
Investigations of 'quantum dots' for looking deeply into body tissues are rapidly evolving, but more work is required to...
FUJIFILM and Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University (Professor Toyohiro Hirai...
Permobil, a global leader in advanced rehabilitation technology, has updated its successful modular front wheel dri...
Daiichi Sankyo has announced the launch of Tarlige® Tablets 2.5 mg, 5 mg, 10 mg, 15 mg (generic name: mirogabal...
Shionogi, Japanese major research-driven pharmaceutical company dedicated to bringing benefits to patients has anno...
HitGen has announced that HitGen Inc. and Kaken Pharmaceutical have entered into a license agreement to develop a n...
EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic disorders ...
Based on its exclusive license related to photoimmunotherapy, Rakuten Medical Inc., which is developing a cancer therapy...
Ajinomoto Bio-Pharma, a leading provider of biopharmaceutical contract development and manufacturing services has a...
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...
Clinigen K.K. and GC Pharma have recently announced an exclusive licensing agreement in Japan to commercialize...
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has acqui...
Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...
Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies ...
Hitachi, Ltd. has announced that the radiation therapy started on April 1, 2019 at Nagamori Memorial Center of Innovativ...
Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, T...
StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...
